Can Osimertinib make tumors disappear?

Osimertinib (Osimertinib) is a targeted drug used to treat specific subtypes of non-small cell lung cancer (NSCLC) and is usually effective in patients with EGFR gene mutations. However, osimertinib does not guarantee the complete disappearance of all tumors, and needs to be evaluated and treated according to the patient's specific situation.

Osimertinib is a potent, orally effective, third-generation EGFR inhibitor that can inhibit the activation of the EGFR signaling pathway, thereby inhibiting the growth of tumor cells. However, tumor is a complex disease that is affected by multiple factors, including genetic mutations, immune responses, environmental factors, etc. Therefore, tumors may continue to grow or develop drug-resistant mutations even with osimertinib treatment. In addition, the use of osimertinib also needs to be evaluated and risk-benefit analyzed based on the patient's specific situation, and needs to be conducted under the guidance of a doctor. During the use of osimertinib, patients need to pay close attention to their physical condition and promptly report any symptoms of discomfort to the doctor so that the doctor can adjust the treatment plan in a timely manner.

OsimertinibThe original drug has been launched in China and has been covered by medical insurance. The price of 80mg*30 tablets per box may be around 5,000 yuan, which is relatively expensive. Currently available overseas Osimertinib generics, such as the specifications produced by Bangladesh Pharmaceutical FactoryThe price of each box of 80mg*30 tablets may be more than 800 yuan (the price may fluctuate due to exchange rate effects), which is relatively cheap. Osimertinib generics have basically the same pharmaceutical ingredients as the original drugs sold domestically and abroad. For more drug information and specific prices, please consult Yaode Medical Consultant.